Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events.

Saved in:
Bibliographic Details
Title: Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events.
Authors: Jacobs SS; Children's National Health System, Washington, District of Columbia, USA., Withycombe JS; Clemson University School of Nursing, Clemson, South Carolina, USA., Castellino SM; Emory University Department of Pediatrics, Aflac Cancer and Blood Disorders center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Lin L; Duke University School of Medicine, Durham, North Carolina, USA., Mack JW; Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts, USA., McFatrich M; Duke University School of Medicine, Durham, North Carolina, USA., Baker JN; St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Freyer DR; Children's Hospital Los Angeles, Los Angeles, California, USA., Maurer SH; UPMC Children's Hospital of Pittsburgh and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Mowbray C; Children's National Health System, Washington, District of Columbia, USA., Hinds PS; Children's National Health System, Washington, District of Columbia, USA., Reeve BB; Duke University School of Medicine, Durham, North Carolina, USA.
Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Dec; Vol. 69 (12), pp. e29986. Date of Electronic Publication: 2022 Sep 24.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1545-5017
DOI:10.1002/pbc.29986